Recurrent supraventricular tachycardia in a newborn treated with amiodarone: is hyperkalemia the apparent cause?

Supraventricular tachycardia (SVT) is the most common type of arrhythmia observed in children, especially in newborns. Infants with severe SVT must be treated immediately with first-line drugs such as amiodarone. There are some minor and major side effects of amiodarone in this patient group, but no...

Full description

Saved in:
Bibliographic Details
Published in:Pediatric cardiology 2005-12, Vol.26 (6), p.879-880
Main Authors: Yildirim, S V, Tiker, F, Cengiz, N, Kiliçdağ, H
Format: Article
Language:English
Subjects:
Amiodarone - therapeutic use
Anti-Arrhythmia Agents - therapeutic use
Arrhythmia
Case studies
Children
Health aspects
Humans
Hyperkalemia - complications
Infant, Newborn
Male
Secondary Prevention
Supraventricular tachycardia
Tachycardia, Supraventricular - drug therapy
Tachycardia, Supraventricular - etiology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c376t-d950aa147196609e7d347af9a64b482d27526bc0a1d14ee79e9eb435d037c1b83
cites cdi_FETCH-LOGICAL-c376t-d950aa147196609e7d347af9a64b482d27526bc0a1d14ee79e9eb435d037c1b83
container_end_page 880
container_issue 6
container_start_page 879
container_title Pediatric cardiology
container_volume 26
creator Yildirim, S V
Tiker, F
Cengiz, N
Kiliçdağ, H
description Supraventricular tachycardia (SVT) is the most common type of arrhythmia observed in children, especially in newborns. Infants with severe SVT must be treated immediately with first-line drugs such as amiodarone. There are some minor and major side effects of amiodarone in this patient group, but no associated electrolyte disorders have been observed. This report describes a newborn whose recurrent SVT attacks during amiodarone treatment were suspected to have been caused by hyperkalemia.
doi_str_mv 10.1007/s00246-005-1043-z
format article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_69070959</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A151959802</galeid><sourcerecordid>A151959802</sourcerecordid><originalsourceid>FETCH-LOGICAL-c376t-d950aa147196609e7d347af9a64b482d27526bc0a1d14ee79e9eb435d037c1b83</originalsourceid><addsrcrecordid>eNptkU2LFDEQhoMo7rj6A7xITt56rXTSSceLLItfsCCInkN1Ur0T7S-T7l1mf71ZZ8DLkkNC5XmKKl7GXgu4EADmXQaola4AmkqAktX9E7YTStaVsEY8ZTsQpq5AK3nGXuT8CwBaaJvn7EzoWjbld8eW7-S3lGhaed6WhLfllaLfBkx8Rb8_eEwhIo8TRz7RXTenia-JcKXA7-K65zjGOWCaJ3rPY-b7w0LpNw40FmvdE8dlwX_9PW6ZPrxkz3ocMr063efs56ePP66-VNffPn-9uryuvDR6rYJtAFEoI6zWYMkEqQz2FrXqVFuH2jS17jygCEIRGUuWOiWbANJ40bXynL099l3S_GejvLoxZk_DgBPNW3baggHb2AJWR_CmDO3i1M9rQn9DEyUcylZ9LOVL0YgCt1AX_uIRvpxQVvaPCuIo-DTnnKh3S4ojpoMT4B5ydMccXcnRPeTo7ovz5jT91o0U_hun4ORf0ceZ8w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>69070959</pqid></control><display><type>article</type><title>Recurrent supraventricular tachycardia in a newborn treated with amiodarone: is hyperkalemia the apparent cause?</title><source>Springer Link</source><creator>Yildirim, S V ; Tiker, F ; Cengiz, N ; Kiliçdağ, H</creator><creatorcontrib>Yildirim, S V ; Tiker, F ; Cengiz, N ; Kiliçdağ, H</creatorcontrib><description>Supraventricular tachycardia (SVT) is the most common type of arrhythmia observed in children, especially in newborns. Infants with severe SVT must be treated immediately with first-line drugs such as amiodarone. There are some minor and major side effects of amiodarone in this patient group, but no associated electrolyte disorders have been observed. This report describes a newborn whose recurrent SVT attacks during amiodarone treatment were suspected to have been caused by hyperkalemia.</description><identifier>ISSN: 0172-0643</identifier><identifier>EISSN: 1432-1971</identifier><identifier>DOI: 10.1007/s00246-005-1043-z</identifier><identifier>PMID: 16235017</identifier><language>eng</language><publisher>United States: Springer</publisher><subject>Amiodarone - therapeutic use ; Anti-Arrhythmia Agents - therapeutic use ; Arrhythmia ; Case studies ; Children ; Health aspects ; Humans ; Hyperkalemia - complications ; Infant, Newborn ; Male ; Secondary Prevention ; Supraventricular tachycardia ; Tachycardia, Supraventricular - drug therapy ; Tachycardia, Supraventricular - etiology</subject><ispartof>Pediatric cardiology, 2005-12, Vol.26 (6), p.879-880</ispartof><rights>COPYRIGHT 2005 Springer</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c376t-d950aa147196609e7d347af9a64b482d27526bc0a1d14ee79e9eb435d037c1b83</citedby><cites>FETCH-LOGICAL-c376t-d950aa147196609e7d347af9a64b482d27526bc0a1d14ee79e9eb435d037c1b83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27923,27924</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16235017$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Yildirim, S V</creatorcontrib><creatorcontrib>Tiker, F</creatorcontrib><creatorcontrib>Cengiz, N</creatorcontrib><creatorcontrib>Kiliçdağ, H</creatorcontrib><title>Recurrent supraventricular tachycardia in a newborn treated with amiodarone: is hyperkalemia the apparent cause?</title><title>Pediatric cardiology</title><addtitle>Pediatr Cardiol</addtitle><description>Supraventricular tachycardia (SVT) is the most common type of arrhythmia observed in children, especially in newborns. Infants with severe SVT must be treated immediately with first-line drugs such as amiodarone. There are some minor and major side effects of amiodarone in this patient group, but no associated electrolyte disorders have been observed. This report describes a newborn whose recurrent SVT attacks during amiodarone treatment were suspected to have been caused by hyperkalemia.</description><subject>Amiodarone - therapeutic use</subject><subject>Anti-Arrhythmia Agents - therapeutic use</subject><subject>Arrhythmia</subject><subject>Case studies</subject><subject>Children</subject><subject>Health aspects</subject><subject>Humans</subject><subject>Hyperkalemia - complications</subject><subject>Infant, Newborn</subject><subject>Male</subject><subject>Secondary Prevention</subject><subject>Supraventricular tachycardia</subject><subject>Tachycardia, Supraventricular - drug therapy</subject><subject>Tachycardia, Supraventricular - etiology</subject><issn>0172-0643</issn><issn>1432-1971</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2005</creationdate><recordtype>article</recordtype><recordid>eNptkU2LFDEQhoMo7rj6A7xITt56rXTSSceLLItfsCCInkN1Ur0T7S-T7l1mf71ZZ8DLkkNC5XmKKl7GXgu4EADmXQaola4AmkqAktX9E7YTStaVsEY8ZTsQpq5AK3nGXuT8CwBaaJvn7EzoWjbld8eW7-S3lGhaed6WhLfllaLfBkx8Rb8_eEwhIo8TRz7RXTenia-JcKXA7-K65zjGOWCaJ3rPY-b7w0LpNw40FmvdE8dlwX_9PW6ZPrxkz3ocMr063efs56ePP66-VNffPn-9uryuvDR6rYJtAFEoI6zWYMkEqQz2FrXqVFuH2jS17jygCEIRGUuWOiWbANJ40bXynL099l3S_GejvLoxZk_DgBPNW3baggHb2AJWR_CmDO3i1M9rQn9DEyUcylZ9LOVL0YgCt1AX_uIRvpxQVvaPCuIo-DTnnKh3S4ojpoMT4B5ydMccXcnRPeTo7ovz5jT91o0U_hun4ORf0ceZ8w</recordid><startdate>200512</startdate><enddate>200512</enddate><creator>Yildirim, S V</creator><creator>Tiker, F</creator><creator>Cengiz, N</creator><creator>Kiliçdağ, H</creator><general>Springer</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200512</creationdate><title>Recurrent supraventricular tachycardia in a newborn treated with amiodarone: is hyperkalemia the apparent cause?</title><author>Yildirim, S V ; Tiker, F ; Cengiz, N ; Kiliçdağ, H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c376t-d950aa147196609e7d347af9a64b482d27526bc0a1d14ee79e9eb435d037c1b83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2005</creationdate><topic>Amiodarone - therapeutic use</topic><topic>Anti-Arrhythmia Agents - therapeutic use</topic><topic>Arrhythmia</topic><topic>Case studies</topic><topic>Children</topic><topic>Health aspects</topic><topic>Humans</topic><topic>Hyperkalemia - complications</topic><topic>Infant, Newborn</topic><topic>Male</topic><topic>Secondary Prevention</topic><topic>Supraventricular tachycardia</topic><topic>Tachycardia, Supraventricular - drug therapy</topic><topic>Tachycardia, Supraventricular - etiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Yildirim, S V</creatorcontrib><creatorcontrib>Tiker, F</creatorcontrib><creatorcontrib>Cengiz, N</creatorcontrib><creatorcontrib>Kiliçdağ, H</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Pediatric cardiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Yildirim, S V</au><au>Tiker, F</au><au>Cengiz, N</au><au>Kiliçdağ, H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Recurrent supraventricular tachycardia in a newborn treated with amiodarone: is hyperkalemia the apparent cause?</atitle><jtitle>Pediatric cardiology</jtitle><addtitle>Pediatr Cardiol</addtitle><date>2005-12</date><risdate>2005</risdate><volume>26</volume><issue>6</issue><spage>879</spage><epage>880</epage><pages>879-880</pages><issn>0172-0643</issn><eissn>1432-1971</eissn><abstract>Supraventricular tachycardia (SVT) is the most common type of arrhythmia observed in children, especially in newborns. Infants with severe SVT must be treated immediately with first-line drugs such as amiodarone. There are some minor and major side effects of amiodarone in this patient group, but no associated electrolyte disorders have been observed. This report describes a newborn whose recurrent SVT attacks during amiodarone treatment were suspected to have been caused by hyperkalemia.</abstract><cop>United States</cop><pub>Springer</pub><pmid>16235017</pmid><doi>10.1007/s00246-005-1043-z</doi><tpages>2</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0172-0643
ispartof Pediatric cardiology, 2005-12, Vol.26 (6), p.879-880
issn 0172-0643
1432-1971
language eng
recordid cdi_proquest_miscellaneous_69070959
source Springer Link
subjects Amiodarone - therapeutic use
Anti-Arrhythmia Agents - therapeutic use
Arrhythmia
Case studies
Children
Health aspects
Humans
Hyperkalemia - complications
Infant, Newborn
Male
Secondary Prevention
Supraventricular tachycardia
Tachycardia, Supraventricular - drug therapy
Tachycardia, Supraventricular - etiology
title Recurrent supraventricular tachycardia in a newborn treated with amiodarone: is hyperkalemia the apparent cause?
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T09%3A41%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Recurrent%20supraventricular%20tachycardia%20in%20a%20newborn%20treated%20with%20amiodarone:%20is%20hyperkalemia%20the%20apparent%20cause?&rft.jtitle=Pediatric%20cardiology&rft.au=Yildirim,%20S%20V&rft.date=2005-12&rft.volume=26&rft.issue=6&rft.spage=879&rft.epage=880&rft.pages=879-880&rft.issn=0172-0643&rft.eissn=1432-1971&rft_id=info:doi/10.1007/s00246-005-1043-z&rft_dat=%3Cgale_proqu%3EA151959802%3C/gale_proqu%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c376t-d950aa147196609e7d347af9a64b482d27526bc0a1d14ee79e9eb435d037c1b83%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=69070959&rft_id=info:pmid/16235017&rft_galeid=A151959802&rfr_iscdi=true